Amlexanox

DB01025

small molecule approved investigational withdrawn

Deskripsi

Amlexanox is an antiallergic drug, clinically effective for atopic diseases, especially allergic asthma and rhinitis. Amlexanox as a topical paste is a well tolerated treatment of recurrent aphthous ulcers. Recurrent aphthous ulcer (RAU) is the most prevalent oral mucosal disease in humans, estimated to affect between 5% and 50% of the general population.

Struktur Molekul 2D

Berat 298.2934
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) Elimination half-life is 3.5 ± 1.1 hours.
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

No significant absorption directly through the active ulcer. Most of the systemic absorption is via the gastrointestinal tract.

Metabolisme

Metabolized to hydroxylated and conjugated metabolites.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

0 Data
Tidak ada data.

Target Protein

Heat shock protein HSP 90-alpha HSP90AA1
Protein S100-A12 S100A12
Protein S100-A13 S100A13
Interleukin-3 IL3
Fibroblast growth factor 1 FGF1

Referensi & Sumber

Artikel (PubMed)
  • PMID: 17532700
    Bell J: Amlexanox for the treatment of recurrent aphthous ulcers. Clin Drug Investig. 2005;25(9):555-66.

Contoh Produk & Brand

Produk: 1 • International brands: 4
Produk
  • Apthera
    Paste • 5 % • Oral • Canada • Approved
International Brands
  • Aphthasol
  • Elics
  • OraDisc A
  • Solfa

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul